We are live on !
Find out more
Royce & Associates Portfolio holdings
AUM
$12.4B
Turnover
20.64%
1-Year Est. Return
64.17%
This Fund
S&P 500
This Quarter Est. Return
+10.53%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$33.6B
AUM Growth
+$1.25B
(+3.9%)
Cap. Flow
-$1.82B
Cap. Flow % of AUM
Cap. Flow %
-5.43%
Top 10 Holdings %
Top 10 Hldgs %
10.25%
Holding
1,526
New
88
Increased
442
Reduced
565
Closed
79
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mativ Holdings
MATV
|
+$106M |
| 2 |
Acacia Research
ACTG
|
+$101M |
| 3 |
Universal Corp
UVV
|
+$47.5M |
| 4 |
PARTNERRE LTD
PRE
|
+$41.9M |
| 5 |
Standard Motor Products
SMP
|
+$41.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MOLXA
MOLEX INC CL-A
MOLXA
|
+$314M |
| 2 |
Nu Skin
NUS
|
+$241M |
| 3 |
Lincoln Electric
LECO
|
+$116M |
| 4 |
HITK
HI-TECH PHARMACAL INC
HITK
|
+$64.5M |
| 5 |
Dorman Products
DORM
|
+$56.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 24.94% |
| 2 | Technology | 17.69% |
| 3 | Consumer Discretionary | 14.45% |
| 4 | Financials | 10.27% |
| 5 | Materials | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1201
Henry Schein
HSIC
$9.6B
| $770K | ﹤0.01% |
18,947
+16,371
| +636% | +$663K |
2013 Q2
1 quarter
|
|
1202
DELISTED
PROTECTIVE LIFE CORP
PL
| $767K | ﹤0.01% |
18,032
-12,897
| -42% | -$551K |
2013 Q2
1 quarter
|
|
1203
Myers Industries
MYE
$1.18B
| $764K | ﹤0.01% |
38,000
+23,300
| +159% | +$434K |
2013 Q2
1 quarter
|
|
|
JOY
1204
DELISTED
Joy Global Inc
JOY
| $755K | ﹤0.01% |
+14,800
| New | +$755K |
2013 Q3
0 quarters
|
|
1205
The Ensign Group
ENSG
$10.3B
| $749K | ﹤0.01% |
71,384
-784
| -1% | -$7.78K |
2013 Q2
1 quarter
|
|
1206
InterDigital
IDCC
$8.24B
| $747K | ﹤0.01% |
20,000
+4,500
| +29% | +$170K |
2013 Q2
1 quarter
|
|
1207
Oceaneering
OII
$4.36B
| $747K | ﹤0.01% |
9,201
| – | – |
2013 Q2
1 quarter
|
|
1208
Douglas Dynamics
PLOW
$912M
| $737K | ﹤0.01% |
50,000
| – | – |
2013 Q2
1 quarter
|
|
|
AFAM
1209
DELISTED
Almost Family Inc
AFAM
| $730K | ﹤0.01% |
37,547
| – | – |
2013 Q2
1 quarter
|
|
1210
Theriva Biologics
TOVX
$9.5M
| $720K | ﹤0.01% |
49
| – | – |
2013 Q2
1 quarter
|
|
|
PLCM
1211
DELISTED
POLYCOM INC
PLCM
| $710K | ﹤0.01% |
65,000
-194,700
| -75% | -$2.03M |
2013 Q2
1 quarter
|
|
1212
Marchex
MCHX
$55.9M
| $692K | ﹤0.01% |
95,000
| – | – |
2013 Q2
1 quarter
|
|
1213
Green Plains
GPRE
$1.01B
| $690K | ﹤0.01% |
43,000
-16,100
| -27% | -$260K |
2013 Q2
1 quarter
|
|
1214
DELISTED
Enstar Group
ESGR
| $683K | ﹤0.01% |
5,000
| – | – |
2013 Q2
1 quarter
|
|
1215
First Bancorp
FNLC
$388M
| $675K | ﹤0.01% |
40,200
| – | – |
2013 Q2
1 quarter
|
|
1216
Comstock
LODE
$136M
| $675K | ﹤0.01% |
1,500
| – | – |
2013 Q2
1 quarter
|
|
|
BMTC
1217
DELISTED
Bryn Mawr Bank Corp
BMTC
| $674K | ﹤0.01% |
25,000
| – | – |
2013 Q2
1 quarter
|
|
|
AHPI
1218
DELISTED
Allied Healthcare Products
AHPI
| $660K | ﹤0.01% |
145,999
+5,677
| +4% | +$28.8K |
2013 Q2
1 quarter
|
|
1219
Kopin
KOPN
$594M
| $657K | ﹤0.01% |
163,025
| – | – |
2013 Q2
1 quarter
|
|
1220
Eastern Company
EML
$146M
| $643K | ﹤0.01% |
39,750
| – | – |
2013 Q2
1 quarter
|
|
1221
DELISTED
TruBridge
TBRG
| $632K | ﹤0.01% |
10,800
| – | – |
2013 Q2
1 quarter
|
|
|
SARA
1222
DELISTED
SARATOGA RESOURCES INC
SARA
| $622K | ﹤0.01% |
261,200
+104,600
| +67% | +$209K |
2013 Q2
1 quarter
|
|
1223
DELISTED
Big 5 Sporting Goods
BGFV
| $617K | ﹤0.01% |
38,400
+8,600
| +29% | +$169K |
2013 Q2
1 quarter
|
|
1224
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$327M
| $617K | ﹤0.01% |
8,200
| – | – |
2013 Q2
1 quarter
|
|
1225
INVE Technologies, Inc. Common Stock
INVE
$53.8M
| $606K | ﹤0.01% |
86,515
+18,500
| +27% | +$142K |
2013 Q2
1 quarter
|
|
Similar funds
Royce & Associates's Q3 2013 Portfolio in Review
As of Q3 2013, Royce & Associates held 1,526 positions worth $33.6B, up 3.9% from $32.4B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Royce & Associates withdrew a net $1.82B in Q3 2013, closing 79 positions and reducing 565 holdings. Its most notable exit was MAIDENFORM BRANDS, INC, an estimated $44.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Royce & Associates opened a new position in Genesco worth $17.8M.
- Royce & Associates's largest Q3 2013 buy was Genesco: 272,129 shares worth $17.8M.
- Royce & Associates added most to Mativ Holdings in Q3 2013, an estimated $106M increase.
- Royce & Associates's biggest Q3 2013 reduction was MOLEX INC CL-A, cutting an estimated $314M.
- Royce & Associates fully exited MAIDENFORM BRANDS, INC in Q3 2013, selling an estimated $44.3M.
- Royce & Associates's ten largest holdings make up 10% of its $33.6B portfolio in Q3 2013.
- Royce & Associates opened 88 new positions and closed 79 in Q3 2013.
- Royce & Associates's portfolio value rose 3.9% quarter-over-quarter to $33.6B.
Based on Royce & Associates's 13F filing for Q3 2013, filed 12 Nov 2013.